Nippon India MNC Fund
The scheme seeks to achieve long-term capital appreciation for its investors. This objective will be pursued by strategically investing in a diversified portfolio of equity and equity-related instruments of multinational companies (MNCs). There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 1/5 — ranked #166 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.01 (as of 2026-10-01) |
|---|
| AUM | ₹435 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dhrumil Shah |
|---|
| Exit load | 1% for redemption within 1 year |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −13.39% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 51.7% of NIFTY CPSE's upside and 42.1% of its downside.
Market cap allocation
| Large cap | 56.5% |
|---|
| Mid cap | 28.1% |
|---|
| Small cap | 15.4% |
|---|
Concentration
| Top 5 holdings | 32.7% |
|---|
| Top 10 holdings | 53.6% |
|---|
| Total holdings | 35 |
|---|
Top holdings
- Nestle India Ltd. — 7.2%
- Cummins India Ltd. — 7.1%
- Maruti Suzuki India Ltd. — 6.8%
- Britannia Industries Ltd. — 6.6%
- HYUNDAI MOTOR INDIA LIMITED — 5.1%
- Hindustan Unilever Ltd. — 4.8%
- Sai Life Sciences Limited — 4.2%
- Triparty Repo — 4.1%
- Fortis Healthcare Ltd — 4.1%
- Kansai Nerolac Paints — 4.0%
Top sectors
- Automobile — 18.9%
- Food Beverage & Tobacco — 17.7%
- Pharma & Biotech — 10.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −7.4% | Q3 | #119 of 167 |